AusBiotech and the Australian Government's Trade and Investment Commission, Austrade, are partnering to accelerate the global growth and expansion of life science companies.
The partnership will introduce a new National TradeStart Adviser role to support Australian biotechnology, pharmaceutical, medical technology, and digital health companies in scaling and growing internationally. The adviser, embedded within AusBiotech, will work directly with life sciences companies across Australia, connecting them with Austrade services and programs globally.
AusBiotech is the first life sciences peak body to join with Austrade as a national partner in delivering TradeStart, joining other industry peak bodies in the program.
AusBiotech CEO Rebekah Cassidy said, "We are delighted to be partnering with Austrade, to have a dedicated TradeStart Adviser to work with Australia’s life science innovators. It will ensure companies across our wider ecosystem have the right support, intelligence, and access to thrive globally.”
“Australia’s life sciences companies are innovating at pace, but navigating global markets can be complex. This new role will help to unlock growth and global pathways by embedding a new and sophisticated level of strategic support directly into our ecosystem.
“With the life sciences sector playing an increasingly strategic role in Australia’s economy, it’s an important proof point in how industry and government can work together to match that potential with the right structures of support,” added Ms Cassidy.
Austrade CEO Dr Paul Grimes PSM said, “This partnership reinforces our commitment to supporting Australian life sciences companies as they scale their businesses globally. By working together with AusBiotech and Australia’s scaleups, we can create even more opportunities for the sector to expand and thrive.”